Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.
about
Immune Cells in Cancer Therapy and Drug DeliveryThe Application of Natural Killer Cell Immunotherapy for the Treatment of CancerSelection and expansion of natural killer cells for NK cell-based immunotherapyEffector Functions of Natural Killer Cell Subsets in the Control of Hematological MalignanciesImproving natural killer cell cancer immunotherapyIL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansionCytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis.The Memories of NK Cells: Innate-Adaptive Immune Intrinsic Crosstalk.Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals.Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patientsIL-12/15/18-preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantationHuman Cytokine-Induced Memory-Like Natural Killer Cells.Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection.Tracking the fate of antigen-specific versus cytokine-activated natural killer cells after cytomegalovirus infection.NK Cells: Uncertain Allies against Malaria.The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia.Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy.Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.Natural killer cell regulation - beyond the receptors.Natural killer cell receptors: alterations and therapeutic targeting in malignancies.NK cell-based cancer immunotherapy: from basic biology to clinical application.The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas.IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo.Enhancement of cytokine-driven NK cell IFN-γ production after vaccination of HCMV infected Africans.MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function.Neonatal respiratory syncytial virus infection has an effect on lung inflammation and the CD4(+) CD25(+) T cell subpopulation during ovalbumin sensitization in adult mice.Harnessing NK Cell Memory for Cancer Immunotherapy.A review on interleukins: The key manipulators in rheumatoid arthritis.Monocyte/Macrophage: NK Cell Cooperation-Old Tools for New Functions.Synergy between Common γ Chain Family Cytokines and IL-18 Potentiates Innate and Adaptive Pathways of NK Cell Activation.Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation.Engineering Natural Killer Cells for Cancer Immunotherapy.Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis?Developmental and Functional Control of Natural Killer Cells by Cytokines.Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells.Tumor-priming converts NK cells to memory-like NK cells.Activation of the FcgammaReceptorIIIa on human natural killer cells leads to increased expression of functional interleukin-21 receptor.Adoptively transferred natural killer cells maintain long-term antitumor activity by epigenetic imprinting and CD4+ T cell help
P2860
Q26747061-956D9162-0A76-4A0D-B058-A5816A67979DQ26774678-B17173C9-4047-4858-8E93-A985C76C686FQ26774777-A1675F72-C6CA-4BFF-A66C-713F1B347873Q26776538-9E668C96-BE15-4F87-B13D-8325BCFF2F8EQ28087719-39F27913-53FC-49A6-9EAF-99510D116115Q28251295-700C3097-7A97-4931-BF5C-E0F654DA2064Q33703046-49C4F156-D394-4D37-9497-A010312A1CB3Q33774531-5374D586-5F44-400E-8F64-90AA689E80A1Q34549025-68656116-3290-411F-B60E-D81417A8701FQ35560718-4C738588-1465-48F7-AD26-9F00E185B1CBQ35575280-91B2E014-447B-4717-9134-D93E2053F35FQ36393953-5903DEE1-D14D-4050-A409-1E9228D18AA2Q36830628-732C9338-CC1D-450C-ACE1-A37020F3EBDCQ37015056-50EECCA1-88C8-4D10-9AC3-4C5E4F055D9FQ37415250-D021886E-07B9-4437-88AD-7EC4885477DAQ37689434-3A285BF9-E15B-4A68-B30B-818CD7181414Q37694772-8B32694A-EB70-48FD-AEFC-642F49E94070Q37739485-A398CA3B-C196-4C0B-80E7-1EA5A327722BQ38233046-F14D202B-A5D3-4545-A5B1-6A2CBD5616C7Q38265518-B91A8F8E-0853-426D-BE67-281F31013EDDQ38587627-D1AA7497-EB2E-4C2B-BF0E-5507FA671920Q38640489-7E18B28E-C33A-496C-8FB9-526F6F2E8306Q38831202-CB92B72E-0A31-4A09-B6D0-477183EC8809Q38839145-C8C9D959-30D3-4443-9546-A5B652AD0426Q38850734-74DB6C9D-DA8F-4F3C-AF38-104B4E1D4776Q38899741-BA42AC7F-2D1F-4894-B324-51BC50157EA0Q38915262-A69ACD4E-B634-4EB4-9EE5-B9AF36A48F8EQ38951265-7966ACCF-E8B4-42C3-A058-0D35369FBEF4Q38988913-A5067AD1-06B3-4C49-A576-7586247AE776Q39029629-773F44D2-FD9B-4565-9E51-4A6F3AB79295Q39271596-3F5F6E39-9379-4BE4-8128-64EC93A582F4Q39296499-F0FA64DA-9229-4D9A-A3DD-46DB2399646AQ39296861-99AAACE0-C33D-429E-A73E-AE045600A27CQ39408704-54825262-2988-40E7-9F25-2E1E0A25B3DFQ40064112-EFD97FA3-B16A-441F-9193-340A79DF6457Q40086298-03EE8CAA-F39A-45EE-A284-569B17FBE3AFQ40089171-F661094D-1156-4A25-894B-F67552E9F747Q40146289-2671A2B6-2B01-41A5-9110-B27BABDA334EQ40150320-97030F88-5DDC-48D7-B301-952AAA253E59Q41298261-E7C7FC37-4C2B-488D-89A3-848AB3261E03
P2860
Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Preactivation with IL-12, IL-1 ...... ory-like natural killer cells.
@en
type
label
Preactivation with IL-12, IL-1 ...... ory-like natural killer cells.
@en
prefLabel
Preactivation with IL-12, IL-1 ...... ory-like natural killer cells.
@en
P2093
P2860
P1476
Preactivation with IL-12, IL-1 ...... mory-like natural killer cells
@en
P2093
Jeffrey W Leong
Julie M Chase
Megan A Cooper
Rizwan Romee
Ryan P Sullivan
Stephanie E Schneider
P2860
P304
P356
10.1016/J.BBMT.2014.01.006
P577
2014-01-13T00:00:00Z